Skip to main content
. 2016 Jun 1;51(2):118–126. doi: 10.1007/s13139-016-0415-z

Table 1.

Advantages of using BMCT

Advantages Detail References
Various administration routes Intravenous [418]
Intraperitoneal [1923]
Intratumoral [19, 2427]
Oral [17, 28, 29]
Broad tumor-targeting ability Colon [7, 9, 10, 14, 19, 24, 30, 31]
Fibrosarcoma [17]
Bladder [13]
Liver [6, 7, 15, 30]
Pancreas [8, 21]
Lung [14, 15]
Melanoma [18, 20, 22, 27, 28, 31, 32]
Breast [4, 11, 12, 16, 23, 25, 31]
Prostate [20, 26]
Flexibility of delivery Protein derived from eukaryotes [5, 12, 20, 29]
Protein derived from prokaryotes [7, 11, 30, 31]
Enzyme-prodrug [4, 13]
DNA [18, 19, 25]
siRNA, shRNA [9, 26, 28]
Facilitating host’s immune responses TAM reduction [16]
Antigen delivery [17, 23, 33]
Upregulation of gap junction [27]
Shift from immune suppressive to immunogenic [22, 24]
Noninvasive monitoring Luminescence [6, 7, 14, 30, 31, 3437]
Fluorescence [8]
MRI [38]
PET [39]
Can be combined with other therapies Chemotherapy [5, 13, 15, 32]
Radiation [12, 21, 31]
Viral therapy [14]